Traj11: A Protein Involved in T Cell Receptor Function and Immune Response

Target Name: TRAJ11

NCBI ID: G28744

TRAJ11

Other Name(s): T cell receptor alpha joining 11

Traj11: A Protein Involved in T Cell Receptor Function and Immune Response

Traj11 (T cell receptor alpha joining 11) is a protein that is expressed in T cells, a type of white blood cell that plays a crucial role in the immune system. The T cells are responsible for recognizing and responding to foreign substances in the body, and Traj11 is a critical receptor that helps them do so.

Research has shown that Traj11 is involved in a wide range of physiological processes in the body, including immune response, inflammation, and cell signaling. It has also been identified as a potential drug target, which means that it could be targeted by drugs in order to treat various diseases.

One of the key functions of Traj11 is its role in the immune response. T cells are a critical part of the immune system, and they help the body to recognize and respond to foreign substances like viruses and bacteria. Traj11 is involved in this process, as it helps T cells to recognize and respond to specific antigens.

Traj11 is also involved in the regulation of inflammation. When the body is exposed to an antigen that it recognizes as foreign, it sends a signal to the immune system to launch an immune response. Traj11 helps to regulate this process, as it helps to ensure that the immune response is appropriate and does not cause unnecessary damage to the body.

In addition to its role in the immune response, Traj11 is also involved in cell signaling. It has been shown to play a role in the regulation of cell proliferation and differentiation, as well as in the regulation of cellular signaling pathways.

Traj11 has also been identified as a potential drug target because of its involvement in a wide range of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases. For example, studies have shown that Traj11 is involved in the regulation of cancer cell growth and has been used as a potential therapeutic target in cancer treatment.

In addition to its potential therapeutic applications, Traj11 is also an important protein for basic research into the immune system and cell signaling. Studies have shown that Traj11 plays a critical role in the regulation of T cell development and function, and have identified its potential as a useful tool for the study of these processes.

Overall, Traj11 is a protein that is involved in a wide range of important physiological processes in the body. Its potential as a drug target makes it an attractive target for research into the treatment of various diseases. Further studies are needed to fully understand the role of Traj11 in the immune system and its potential as a therapeutic agent.

Protein Name: T Cell Receptor Alpha Joining 11

The "TRAJ11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRAJ11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets